Omeros (NASDAQ:OMER) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.52) by 46.15 percent. This is a 22.22 percent increase over losses of $(0.36) per share from the same period last year.
Guggenheim Initiates Coverage On SCYNEXIS with Buy Rating, Announces Price Target of $8
Guggenheim analyst Vamil Divan initiates coverage on SCYNEXIS (NASDAQ:SCYX) with a Buy rating and announces Price Target of $8.